We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 78

Omnibus claims: Back to business as usual
  • Minter Ellison
  • Australia
  • July 19 2016

The Full Federal Court has recently handed down its decision in the appeal by GlaxoSmithKline (GSK) against the earlier finding by Justice Rares


"Just DAST it" - Gilead succeeds on insufficiency and inutility for Hepatitis C treatment
  • Minter Ellison
  • Australia
  • March 29 2016

Gilead commenced proceedings against Idenix seeking revocation of Idenix's Australian patent No 2003247084 (Patent). The Patent was filed on 27 June


Planning for privacy in health research
  • Minter Ellison
  • Australia
  • August 8 2016

Information is critical to the conduct of health and medical research. Much of the time the information relates to individuals. Higher education


Exclusive patent licences and standing to sue - a green light for commercial 'work arounds'
  • Minter Ellison
  • Australia
  • December 21 2015

In Orion Corporation v Actavis Pty Ltd (No 3) 2015 FCA 1373, the Federal Court has provided practical guidance on drafting an exclusive patent


Servier fails on best method - Full Federal Court confirms invalidity and denies application to amend
  • Minter Ellison
  • Australia
  • March 18 2016

This decision is interesting as it deals with four pertinent topics - the best method requirement patent amendment applications cost


Watch out for a wide omnibus (claim)
  • Minter Ellison
  • Australia
  • July 30 2015

Old-style 'omnibus claims' are often overlooked in patent infringement disputes. The usual assumption is that these claims are very narrow in scope


Update: Servier successful in stay application - Apotex kept off the market while Servier appeals to the High Court
  • Minter Ellison
  • Australia
  • March 31 2016

Servier was successful in yesterday's hearing of its stay application. As a result, the orders which revoked Servier's patent and discharged the


Health & Ageing sector - increasing investment opportunities
  • Minter Ellison
  • Australia, China
  • February 26 2016

Increased deal activity is likely in Australia's health and aged care sector in 2016, driven by: investment interest from China Australian players


2015 Patent recap: The 8 (patent) days of Christmas
  • Minter Ellison
  • Australia
  • December 9 2015

The High Court of Australia rarely considers patent cases, handing down only two decisions in the past seven years. This year, however, we saw two


Agreed or liquidated damages that are neither extravagant nor unconscionable are not penal and therefore are recoverable
  • Minter Ellison
  • Australia
  • September 4 2015

Agreed damages were found not to be extravagant or unconscionable, therefore not a penalty. Facts On 3 October 2007, IPN Medical Centres Pty Ltd